Comparison · NCT02790463-sae
Intervention vs Usual Care: serious adverse events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Intervention vs Usual Care: serious adverse events. Trial comparisons, record NCT02790463-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02790463-sae
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.00147 | 0.000259 | 0.00827 | wilson | |
| Risk in group 2 | 0.00128 | 0.000226 | 0.00721 | wilson | |
| Risk difference, group 1 minus group 2 | 0.00019 | -0.00586 | 0.00707 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.15 | 0.072 | 18.3 | log | |
| Odds ratio, group 1 over group 2 | 1.15 | 0.0717 | 18.4 | log | |
| Number needed to harm, for one more participant with a serious adverse event on Intervention than on Usual Care | 5,270 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: usual care.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Intervention | Participants recruited to this arm will receive their usual gout care + pharmacist-led intervention~Pharmacist-Led Intervention: Pharmacists will conduct outreach primarily via an automated telephone interactive voice recognition system and direct (telephone) contact | 1 | 681 | EG001 |
| Group 2 | Usual Care | Participants recruited in this arm will receive their usual care for gout as they normally would | 1 | 782 | EG000 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, serious adverse events
- Time frame
- 2 year study period
Source ClinicalTrials.gov
Trial
- Title
- Virtual Gout Clinic
- NCT number
- NCT02790463
- Phases
- NA
- Conditions
- Gout
- Interventions
- Pharmacist-Led Intervention
- Lead sponsor
- University of Alabama at Birmingham
- Results first posted
- 2019-11-12
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02790463?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02790463-sae